Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | QPCT | Q16769 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 6/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | HTT | P42858 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25840801 | 0.91 | SMN1; SMN2 (0.54) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL25840803 | 0.84 | ALDH1A1 (0.59) | SMN1; SMN2KMT2AMEN1HTTALDH1A1 | |
| SCHEMBL23328449 | 0.82 | MEN1 (0.67) | SMN1; SMN2LMNAKMT2AMEN1HTT | |
| SCHEMBL25840787 | 0.81 | SMN1; SMN2 (0.57) | RECQLSMN1; SMN2LMNAKMT2AMEN1 | |
| SCHEMBL27941612 | 0.79 | RECQL (0.54) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL29043442 | 0.78 | RECQL (0.53) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL25840781 | 0.78 | RECQL (0.56) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL17982696 | 0.77 | LMNA (0.65) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL20079588 | 0.76 | POLB (0.57) | RECQLQPCTSMN1; SMN2LMNAKMT2A | |
| SCHEMBL11772198 | 0.76 | CDK1 (0.63) | RECQLQPCTSMN1; SMN2LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | Kent Innovation & Enterprise (GB) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | ARF1, ARL1, TLR1 | RECQL 2422/4885QPCT 2942/4885SMN1; SMN2 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.